Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WORX vs NRC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NRC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

NRC Overall Winner 6-Pillar Tally: WORX 1 – 4 NRC (1 Tie) Matrix Metrics: WORX 1 – 9 NRC

As of Nov 16, 2026, National Research Corporation (NRC) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WORX carries a Unified Composite Score of 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin), whereas NRC carries 32.4/100 (SELL) at $26.33 (24.8x Forward P/E, 13.4% operating margin).

  • Composite vs. Pillar Nuance: While WORX currently prints a higher short-term Unified Composite Score (34.1/100 SELL vs. NRC 32.4/100 SELL), NRC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (13.4% vs. -20.1% operating margin) and revenue trajectory (+11.0% vs. +3.4% YoY).
  • Defensive Composite Rating Caution: Although NRC compares more favorably head-to-head, both WORX (34.1/100 SELL) and NRC (32.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WORX vs NRC
WORX NASDAQ
SC WORX Corp
Services-Computer Processing & Data Preparation
$1.15
-6.5% 1D
Market Cap $1.7M
TTM Revenue $2.9M
Forward P/E N/M
Beta / 30D Vol 23.01β · 208% Vol
Unified Composite Score
34.1 / 100 SELL
Tech 15.0 Fund 31.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 71
RSI-14: 71.4 · SMA20: $0.24 · SMA50: $0.24
NRC NASDAQ Head-to-Head Winner
National Research Corporation Common Stock (Delaware)
Services-Commercial Physical & Biological Research
$26.33
-0.87% 1D
Market Cap $563.6M
TTM Revenue $144M
Forward P/E 24.8x
Beta / 30D Vol 0.64β · 61% Vol
Unified Composite Score
32.4 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 64
RSI-14: 63.7 · SMA20: $24.29 · SMA50: $22.22

6-Pillar Scorecard Institutional Category Breakdown (WORX 1 – 4 NRC)

Columns: Metric · WORX · NRC
1. Valuation Multiples NRC
Forward P/E N/M 24.8x
Trailing P/E N/M 98.4x
PEG Ratio N/M 1.32x
EV / Revenue 0.6x 3.9x
2. Growth & Scale NRC
Revenue Growth (YoY) +3.4% +11.0%
Earnings Growth (YoY) +0.0% +16.7%
TTM Revenue (USD) $2.9M $144M
Market Cap $1.7M $563.6M
3. Profitability & Quality NRC
Gross Margin 44.7% 60.7%
Operating Margin -20.1% 13.4%
Net Profit Margin -80.5% 4.5%
Return on Equity (ROE) -38.1% 248.1%
4. Balance Sheet & Cash Flow NRC
Cash Generation (TTM) -$914,262 $28M EBITDA
Cash Flow Margin -31.2% 19.3% EBITDA Mgn
Net Cash / Leverage $77.66 Book/Sh · -38.1% ROE 248.1% ROE
Dividend Yield None (0.00%) 2.40%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 98.1% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat WORX
OpEx & R&D Intensity 64.8% of Rev ($1.9M) 47.3% of Rev ($68M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Health Information Services Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WORX (1) vs NRC (9)
Institutional Metric WORX NRC Criterion Row Edge
Market Capitalization
Scale
$1.7M $563.6M Larger Scale NRC
Trailing P/E Ratio
Valuation
N/M 98.4x Lower Multiple NRC
Forward P/E Ratio
Valuation
N/M 24.8x Lower Multiple NRC
Revenue Growth (YoY)
Growth
+3.4% +11.0% Higher Growth NRC
Operating Margin (TTM)
Profitability
-20.1% 13.4% Higher Margin NRC
Net Profit Margin
Profitability
-80.5% 4.5% Higher Margin NRC
Return on Equity (ROE)
Capital Efficiency
-38.1% 248.1% Higher ROE NRC
52-Week Range Position
Momentum
17% ($0–$6) 92% ($12–$28) Stronger Trend NRC
Beta / 30D Volatility
Risk Regime
23.01β · 208% Vol 0.64β · 61% Vol Lower Realized Risk NRC
Unified Institutional Score
Composite Signal
34.1 / 100 (SELL) 32.4 / 100 (SELL) Higher Composite WORX
Trailing 12M Revenue (USD)
Operating Scale
$2.9M $144M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.7% 60.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.6x EV/Rev 1.32x PEG · 3.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$914,262 ($77.66 Book/Sh · -38.1% ROE) $28M EBITDA (248.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NRC +47.34 pp
WORX: -16.67% · NRC: +30.67%
3M Horizon WORX +117.74 pp
WORX: +228.38% · NRC: +110.64%
6M Horizon WORX +265.92 pp
WORX: +327.35% · NRC: +61.43%
1Y Horizon WORX +193.35 pp
WORX: +262.78% · NRC: +69.43%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WORX vs NRC. Trailing 12-month operating profitability (WORX -20.1% vs NRC 13.4%) and valuation multiples (WORX N/M vs NRC 24.8x Forward P/E) are benchmarked directly in Pillar 4 below.

WORX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.9M
Gross Margin44.7%
Op. Margin-20.1%
ROE / Fwd P/E-38.1% · N/M
NRC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$144M
Gross Margin60.7%
Op. Margin13.4%
ROE / Fwd P/E248.1% · 24.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WORX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WORX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NRC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 98.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WORX Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $1.7M market capitalization and -20.1% operating margin.
OpEx & R&D Reinvestment 64.8% of Rev ($1.9M)
90D Engineering Disclosures 0 Published
NRC Moat Profile High-Margin Pricing Power Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $563.6M market capitalization and 13.4% operating margin.
OpEx & R&D Reinvestment 47.3% of Rev ($68M)
90D Engineering Disclosures 0 Published

Investor FAQ WORX vs NRC Key Questions & Quantitative Answers

As of Nov 16, 2026, National Research Corporation (NRC) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WORX carries a Unified Composite Score of 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin), whereas NRC carries 32.4/100 (SELL) at $26.33 (24.8x Forward P/E, 13.4% operating margin). Composite vs. Pillar Nuance: While WORX currently prints a higher short-term Unified Composite Score (34.1/100 SELL vs. NRC 32.4/100 SELL), NRC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (13.4% vs. -20.1% operating margin) and revenue trajectory (+11.0% vs. +3.4% YoY). Defensive Composite Rating Caution: Although NRC compares more favorably head-to-head, both WORX (34.1/100 SELL) and NRC (32.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

NRC leads the Growth & Scale pillar: WORX posts +3.4% YoY revenue growth and +0.0% YoY earnings growth on $2.9M TTM revenue (44.7% gross margin, -20.1% operating margin), compared with NRC at +11.0% YoY revenue growth and +16.7% YoY earnings growth on $144M TTM revenue (60.7% gross margin, 13.4% operating margin). On trailing 12-month operating scale, WORX generates $2.9M in USD-normalized revenue versus $144M for NRC. In operating R&D and SG&A reinvestment, WORX deploys 64.8% of Rev ($1.9M) (0 90-day corporate R&D disclosures) versus 47.3% of Rev ($68M) (0 disclosures) for NRC.

NRC screens cheaper on headline valuation multiples. WORX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-31.2% FCF margin), whereas NRC trades at 24.8x Forward P/E, 98.4x Trailing P/E, 1.32x PEG, and 3.9x EV/Revenue (19.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WORX (-38.1% ROE) versus NRC (248.1% ROE) capital efficiency.

In options market volatility and institutional positioning, WORX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.01β · 208% Vol realized risk). By comparison, NRC carries 98.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.64β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.